Proteogenomic profiling uncovers differential therapeutic vulnerabilities between TCF3::PBX1 and TCF3::HLF translocated B-cell acute lymphoblastic leukemia. - Blumel L; Bernardi F; Picard D; Diaz JT; Jepsen VH; Hasselmann R; Schliehe-Diecks J; Bartl J; Qin N; Bornhauser B; Bhatia S; Marovka B; et al. (Haematologica, 2024)